Korea Investment CORP Purchases 26,101 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Korea Investment CORP increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 115.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,801 shares of the biotechnology company’s stock after buying an additional 26,101 shares during the period. Korea Investment CORP owned about 0.06% of Axon Enterprise worth $29,003,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in AXON. Vanguard Group Inc. grew its holdings in shares of Axon Enterprise by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock valued at $5,019,886,000 after buying an additional 275,959 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after buying an additional 35,320 shares in the last quarter. GQG Partners LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $478,349,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares during the period. Finally, Groupama Asset Managment acquired a new position in Axon Enterprise during the third quarter worth $200,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Trading Down 2.9 %

Shares of AXON opened at $534.95 on Friday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $40.99 billion, a P/E ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12. The firm’s 50-day moving average is $589.62 and its two-hundred day moving average is $547.97.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, The Goldman Sachs Group lifted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.